Mutating mice with oligos

The results reported by Vasquez et al. in the 20 October Science sound like a dream come true: the induction, after a simple injection of oligonucleotides into adult mice, of site-specific mutations (Science 2000, 290:530-533). The oligonucleotides are designed to form triple helices in polypurine regions with segments of mononucleotide repeats. The triple helix is thought to induce repair processes that often slip, producing short insertions or deletions near the site of the triple helix. Thus

Written byWilliam Wells
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The results reported by Vasquez et al. in the 20 October Science sound like a dream come true: the induction, after a simple injection of oligonucleotides into adult mice, of site-specific mutations (Science 2000, 290:530-533). The oligonucleotides are designed to form triple helices in polypurine regions with segments of mononucleotide repeats. The triple helix is thought to induce repair processes that often slip, producing short insertions or deletions near the site of the triple helix. Thus the mutagenesis is specific to a particular gene, but not to a particular base. The frequency of mutagenesis is also very low. Mice treated with five intraperitoneal injections of the oligonucleotide show mutation at the target gene at a rate of approximately 2.7 x 10-5, or five times above background. Nevertheless, it is impressive that any oligonucleotide can make it from the peritoneum into the nuclei of cells in the liver, skin, kidney and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform